Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS Q5121 is classified under Temporary Codes, in the Cancer, Vision and Other Associated Drugs subgroup.
| Key Fact | Detail |
|---|---|
| Service Type | Temporary Codes Cancer, Vision and Other Associated Drugs |
| Complexity Level | Low |
| Medicare Fee Schedule | $34.69 per 10 mg (October 2026 ASP) · View Medicare rates for Q5121 |
| Medicaid Fee Schedule | $30.54 median of the 8 states in the free preview · View Medicaid rates for Q5121 |
| Medicare Payment Limit | |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 55513067001 - AVSOLA (infliximab-axxq) 100 mg/10mL, injection, powder, lyophilized, for solution • 55513067021 - Avsola Inj 100mg, Avsola |
National average reimbursement for HCPCS Q5121 by major payers:

$26.13
BCBS / Anthem

$37.56
UnitedHealthcare

$26.11
Aetna

$23.24
Cigna
Choose a payer to see a sample of rates for HCPCS Q5121.
Emily Felzenberg
Grand Itasca Clinic And Hospital
Rupinder Chawla
Chawla Consultants
Joel Nwosu-Nelson
Muhammad Hanif
Sound Inpatient Physicians, PLLC
Herbert Rosengarten
Choose your state and specialty to build a report from payer-published rates.
Rate Benchmarking
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonPayer Contract Negotiation
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS Q5121 vs. Other Cancer, Vision and Other Associated Drugs Codes
The table lists codes related to Q5121. Select one to see its fee schedule.
| Code | Complexity | Description |
|---|---|---|
| 55513067001-NDC | Moderate | AVSOLA (infliximab-axxq) 100 mg/10mL, injection, powder, lyophilized, for solution |
| 55513067021-NDC | Moderate | Avsola Inj 100mg, Avsola |
| Q5120-HCPCS | Low | Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg |
| Q5121-HCPCS | Low | Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS Q5121. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the Q5121 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
Bring your top codes (like HCPCS Q5121) and we'll show you how you compare in 15 minutes or less.